Comprised of participants reporting myalgia/arthralgia at 12 months and distinguished by lower total lymphocytes with reduced CD3+, CD3+CD4+, and CD19+ counts, suggesting a broader low-grade immune insufficiency rather than isolated activation. The gene discussed is CD19; the disease is Myalgia.